As of May, 8 STERIS plc (STE) EPS Estimated At $1.22

April 17, 2018 - By Joseph Norton

STERIS plc (NYSE:STE) Corporate Logo
Big Money Sentiment decreased to 0.17 in 2017 Q4. It has change of 0.33, from 2017Q3’s 0.5. The ratio dropped due to STERIS plc positioning: 4 sold and 2 reduced. 1 funds amassed holdings and 0 increased holdings. Investors holded 137,131 in 2017Q3 but now own 19,649 shares or 85.67% less.
Hanson And Doremus Inv Mngmt invested in 1,500 shs. Alphamark Lc stated it has 0.01% of its capital in STERIS plc (NYSE:STE). Shine Inv Advisory Ser holds 123 shs or 0.01% of its capital. Moreover, Prudential Public Limited Com has 0% invested in STERIS plc (NYSE:STE) for 3,800 shs. Fruth Invest Management invested in 14,076 shs.

STERIS plc (NYSE:STE)’s quarterly earnings will be reported On May, 8., according to Zacks. Analysts predict $1.22 earnings per share. That’s $0.11 up or 9.91 % from 2017’s earnings of $1.11. If earnings per share of $1.22 is reported the profit of STE could be $103.51 million giving it 19.65 P/E. 8.93 % EPS growth is what Wall Street’s predicts after $1.12 reported EPS last quarter. Its shares touched $95.89 on during the last trading session after 1.57% change.Currently STERIS plc is uptrending after 32.31% change in last April 17, 2017. STE has 230,237 shares volume. STE outperformed the S&P 500 by 20.76%.

STERIS plc (NYSE:STE) Ratings Coverage

In total 3 analysts cover Steris Corp (NYSE:STE). “Buy” rating has 2, “Sell” are 0, while 1 are “Hold”. 67% are bullish. 5 are the (NYSE:STE)’s analyst reports since October 17, 2017 according to StockzIntelligence Inc. On Thursday, February 8 the firm has “Buy” rating given by Northcoast. On Thursday, November 2 the rating was maintained by KeyBanc Capital Markets with “Buy”. On Wednesday, January 3 the rating was downgraded by Raymond James to “Market Perform”. On Tuesday, October 17 KeyBanc Capital Markets maintained STERIS plc (NYSE:STE) rating. KeyBanc Capital Markets has “Buy” rating and $91.0 target. On Thursday, February 8 KeyBanc Capital Markets maintained STERIS plc (NYSE:STE) with “Buy” rating.

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support services and products for healthcare, pharmaceutical, scientific, research, industrial, and governmental clients worldwide.The company has $8.14 billion market cap. The company??s Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories.The P/E ratio is 33.78. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products.

STERIS plc (NYSE:STE) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.